Acellular Dermis Obtainment to Fibroblastic Cell Culture and Tissue Engineering

Article Preview

Abstract:

Tissue injuries are the main factors that lead to treatment by skin culture. In cases where the damage is extensive patient has insufficient amount of tissue to recover the area lost. A possible solution is the use of tissue engineering. Dermal substitutes must provide features and functions as close as possible to the normal skin. The acellular dermis can be obtained from the own patient and represents a viable alternative as a graft. The acellular dermis is used as a dermal analogue to the implantation of cells for tissue engineering treatment. The aim of this study was to compare different ways of obtaining mouse skin acellular dermis and characterize this dermis by macroscopic visualization, light and atomic force microscopy and cell culture.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

122-127

Citation:

Online since:

September 2014

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2015 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] B. Zavan; V. Vindigni, R. Cortivo and G. Abatangelo. Skin Substitutes. In: D. Eberli (Ed. Tissue Engineering, In-Tech, Olajnica, 2010) pp.509-524.

DOI: 10.5772/8588

Google Scholar

[2] I.V. Yannas, J.F. Burke, P.L. Gordon, C. Huang and R.H. Rubenstein: J. Biomed. Mater. Res. Appl Biomat Vol. 14 (1980), p.107.

Google Scholar

[3] I.V. Yannas and J.F. Burke, Design of an artificial skin 1: Basic design principles. J. Biomed. Mater. Res. Appl Biomat Vol. 14 (1980), p.65.

DOI: 10.1002/jbm.820140108

Google Scholar

[4] R. Lanza, R. Langer and J. Vacanti: Principles of Tissue Engeneering. (Thirth edition, Elsevier/Academic Press, Oxford, 2007).

Google Scholar

[5] A.R. Santos Jr and M.L.F. Wada: Polimeros Cienc. Tecnol. Vol. 17 (2007), p.308.

Google Scholar

[6] C. Cuono, R, Langdon and J. McGuire: Lancet Vol. 327 (1986), p.1123.

Google Scholar

[7] M.R. Herson, M.B. Mathor, S. Altran, V.L. Capelozzi and M.C. Ferreira: Artif. Organs Vol. 25 (2001), p.901.

Google Scholar

[8] S. Griffey, N.D. Schwade and C.G. Wright: J. Biomed. Mater. Res. (Appl Biomat) Vol. 58 (2001), p.10.

Google Scholar

[9] K.H. Chakrabarty, R.A. Dawson, P. Harris, C. Layton, M. Babu, L. Gould: J. Dermatol. Vol. 141 (1999), p.811.

Google Scholar

[10] H.O. Ho, Y.T. Tsai, R.N. Chen and M.T. Sheu: J. Biomed. Mater. Res. (Appl Biomat) Vol. 70 A (2004), p.83.

Google Scholar

[11] J.A. Lofego Filho, P.R.C. Souza, M.A.L. Silva, R. Borojevic, B.M.O. Pascarelli, L.F. Oliveira and C.M. Takiya: An. Bras. Dermatol. Vol. 83 (2008), p.25.

Google Scholar

[12] C.J. Kirkpatrick: Reg. Affairs Vol. 4 (1992), p.13.

Google Scholar

[13] International Standart (1992): Biological evaluation of medical devices - Part 5. Tests for cytotoxicity: in vitro methods. ISO 10993-5, 1992(E).

Google Scholar

[14] F.A. Auger, D. Lacroix and L. Germain: Physiol. Vol. 22 (2009), p.94.

Google Scholar

[15] A.R. Santos Jr, H. Dolder, M.L.F. Wada: J. Submicrosc. Cytol. Pathol. Vol. 35 (2003), p.35.

Google Scholar

[16] V.R. Haas, A.R. Santos Jr and M.L.F. Wada: Cytobios Vol. 106 (2) (2001), p.255.

Google Scholar